Abstract:Screening for circulating tumor cells (CTCs) in blood has been an object of interest for evidence of progressive disease, status of disease activity, recognition of clonal evolution of molecular changes and for possible early diagnosis of cancer. We describe a new method of microchip-based immunomagnetic CTC detection, in which the benefits of both immunomagnetic assay and the microfluidic device are combined. As the blood sample flows through the microchannel closely above arrayed magnets, cancer cells labeled with magnetic nanoparticles are separated from blood flow and deposited at the bottom wall of the glass coverslip, which allows direct observation of captured cells with a fluorescence microscope. A polydimethylsiloxane (PDMS)-based microchannel fixed on a glass coverslip was used to screen blood samples. The thin, flat dimensions of the microchannel, combined with the sharp magnetic field gradient in the vicinity of arrayed magnets with alternate polarities, lead to an effective capture of labeled cells. Compared to the commercially available CellSearch™ system, fewer (25%) magnetic particles are required to achieve a comparable capture rate, while the screening speed (at an optimal blood flow rate of 10 mL h(-1)) is more than five times faster than those reported previously with a microchannel-based assay. For the screening experiment, blood drawn from healthy subjects into CellSave™ tubes was spiked with cultured cancer cell lines of COLO205 and SKBR3. The blood was then kept at room temperature for 48 hours before the screening, emulating the actual clinical cases of blood screening. Customized Fe(3)O(4) magnetic nanoparticles (Veridex Ferrofluid™) conjugated to anti-epithelial cell adhesion molecule (EpCAM) antibodies were introduced into the blood samples to label cancer cells, and the blood was then run through the microchip device to capture the labelled cells. After capture, the cells were stained with fluorescent labelled anti-cytokeratin, DAPI and anti-CD45. Subsequent immunofluorescence images were taken for the captured cells, followed by comprehensive computer aided analysis based on fluorescence intensities and cell morphology. Rare cancer cells (from ∼1000 cells down to ∼5 cells per mL) with very low tumor cell to blood cell ratios (about 1 : 10(7) to 10(9), including red blood cells) were successfully detected. Cancer cell capture rates of 90% and 86% were demonstrated for COLO205 and SKBR3 cells, respectively.

Multi-Marker Immunomagnetic Enrichment of Circulating Melanoma Cells

Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.

Generally Applicable Circulating Tumor Cell Enrichment and Identification Through a Membrane Glycoprotein-Targeting Strategy Combining Magnetic Isolation and Biological Orthogonality Labeling.

Enhanced and High-Purity Enrichment of Circulating Tumor Cells Based on Immunomagnetic Nanospheres

Cancer-leukocyte Hybrid Membrane-Cloaked Magnetic Beads for the Ultrasensitive Isolation, Purification, and Non-Destructive Release of Circulating Tumor Cells.

High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications

Greatly isolated heterogeneous circulating tumor cells using hybrid engineered cell membrane-camouflaged magnetic nanoparticles

Hybrid Extracellular Vesicles‐Liposomes Camouflaged Magnetic Vesicles Cooperating with Bioorthogonal Click Chemistry for High‐Efficient Melanoma Circulating Tumor Cells Enrichment

General Applicable Circulating Tumor Cell Enrichment and Identification Through the Membrane Glycoprotein-targeted Strategy Combining Magnetic Isolation and Biological Orthogonality Labeling

Sensitive and direct detection of circulating tumor cells by multimarker µ-nuclear magnetic resonance

Microchip-based immunomagnetic detection of circulating tumor cells

Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis

Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device

A chip assisted immunomagnetic separation system for the efficient capture and in situ identification of circulating tumor cells

Biotin-triggered Decomposable Immunomagnetic Beads for Capture and Release of Circulating Tumor Cells.

Chip-Assisted Single-Cell Biomarker Profiling of Heterogeneous Circulating Tumor Cells Using Multifunctional Nanospheres

Size-Based Method for Enrichment of Circulating Tumor Cells from Blood of Colorectal Cancer Patients

Enrichment and detection of circulating tumor cells by immunomagnetic beads and flow cytometry

Gradient Magnetic Separation and Fluorescent Imaging‐Based Heterogeneous Circulating Tumor Cell Subpopulations Assay with Biomimetic Multifunctional Nanoprobes

Detection of Circulating Tumor Cells Using a Novel Immunomagnetic Bead Method in Lung Cancer Patients

High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (ctcs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles